The Effect of Chlorella Vulgaris Supplementation on Metabolic, Blood Pressure and Antropometric Indices on Non-alcoholic fatty liver disease (NAFLD) patients
Not Applicable
- Conditions
- on-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT2012110911220N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Liver steatosis on sonographic image; 20-50 years old; BMI>=30; moderately activity. Exclusion criteria: Alcohol intake more than 20g/d; gestation or lactation or Menopause; very active or inpatients; Cardiovascular disease; Pulmonary disease; renal disease; liver transplantation; other liver diseases and chronic or acute liver disease(Hepatitis A,B, ...); bilious impairments; cancers; inheritance diseases; using drugs like, insulin sensitivity enhancer, hepatotoxic drugs and estrogen
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver Enzyme (ALT,AST,ALP). Timepoint: Beginning and end of the intervention. Method of measurement: IFCC.;Liver steatosis. Timepoint: Begining and end of intervention. Method of measurement: Liver Sonography.;FBS. Timepoint: Begining and end of intervention. Method of measurement: Enzymatic method.;TC, TG, LDL-C, HDL_c. Timepoint: Begining and end of intervention. Method of measurement: Enzymatic method forTC,TG and HDL-c for LDL-c:Freid wals formula.;Blood pressure. Timepoint: Begining and end of intervention. Method of measurement: Mercury manometer.;Anthropometry. Timepoint: Begining and end of intervention. Method of measurement: Scale and meter.
- Secondary Outcome Measures
Name Time Method Energy and nutrient intake. Timepoint: beginning and end of the intervention. Method of measurement: Dietary record and food frequency questionnaire.